ArticlePharmaceuticals (Basel, Switzerland)2025
In Vitro and In Vivo Effects of Resveratrol on Rat Hepatic CYP1A2.
Sandra Luz Hernández-Ojeda, Raquel López-Arellano, Carla O Contreras-Ochoa, Daniel Hernandez-Patlan, Rafael Camacho-Carranza, Antonio Romo-Mancillas, Giovanny Aguilera-Durán, Carlos A Hernández-Gallardo, Ricardo I Cárdenas-Ávila, Tzipe S Govezensky and 2 more
Abstract read
In one paragraphArticle in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Sandra Luz Hernández-OjedaInstituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Tercer Circuito Exterior, Ciudad Universitaria, Ciudad de México 04510, Mexico.ORCID 0000-0003-4323-394X Raquel López-ArellanoLaboratorio 5: Laboratorio de Ensayos de Desarrollo Farmacéutico (LEDEFAR), Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México, Cuautitlán Izcalli 54714, Estado de México, Mexico.ORCID 0000-0002-2050-6119 Carla O Contreras-OchoaCentro de Investigación Sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Av. Universidad no. 655, Santa María Ahuacatitlán, Cuernavaca 62100, Morelos, Mexico.
Daniel Hernandez-PatlanLaboratorio 5: Laboratorio de Ensayos de Desarrollo Farmacéutico (LEDEFAR), Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México, Cuautitlán Izcalli 54714, Estado de México, Mexico.ORCID 0000-0002-9419-2669 Rafael Camacho-CarranzaInstituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Tercer Circuito Exterior, Ciudad Universitaria, Ciudad de México 04510, Mexico.ORCID 0000-0003-0693-8449 Antonio Romo-MancillasGrupo de Diseño Asistido Por Computadora y Síntesis de Fármacos, Facultad de Química, Universidad Autónoma de Querétaro, Centro Universitario, Querétaro 76010, Mexico.ORCID 0000-0003-2869-588X Giovanny Aguilera-DuránLaboratorio de Química Cuántica y Modelado Molecular, Unidad Académica de Ciencias Químicas, Universidad Autónoma de Zacatecas, Zacatecas 98160, Mexico.ORCID 0000-0003-3376-2477 Carlos A Hernández-GallardoInstituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Tercer Circuito Exterior, Ciudad Universitaria, Ciudad de México 04510, Mexico.ORCID 0009-0009-9517-4452 Ricardo I Cárdenas-ÁvilaInstituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Tercer Circuito Exterior, Ciudad Universitaria, Ciudad de México 04510, Mexico.ORCID 0009-0001-0801-9174 Tzipe S GovezenskyInstituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Tercer Circuito Exterior, Ciudad Universitaria, Ciudad de México 04510, Mexico.
Elvia A Morales-HipólitoLaboratorio 5: Laboratorio de Ensayos de Desarrollo Farmacéutico (LEDEFAR), Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México, Cuautitlán Izcalli 54714, Estado de México, Mexico.
Javier J Espinosa-AguirreInstituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Tercer Circuito Exterior, Ciudad Universitaria, Ciudad de México 04510, Mexico.
Funding
Universidad Nacional Autónoma de México DGAPA-PAPIIT IG200923
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
chemopreventionCYP inhibitioncytochrome P450resveratrol
Identifiers
PMID41304880
PMCPMC12655445
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390